Skip to main content
Top
Published in: Reproductive Health 1/2017

Open Access 01-12-2017 | Research

Utilization of dual contraception method among reproductive age women on antiretroviral therapy in selected public hospitals of Northern Ethiopia

Authors: Solomon Weldemariam Gebrehiwot, Gedion Asnake Azeze, Carmen C. Robles, Yohannes Mehretie Adinew

Published in: Reproductive Health | Issue 1/2017

Login to get access

Abstract

Background

Sexually transmitted infections are highly prevalent among pregnant women in Africa. Among the incidence of HIV infection in children, 90% of the infection is attributable to their mothers. Ethiopia is one of the countries with an increasing risky sexual behavior and the most affected by the HIV epidemic. If prevention of mother to child transmission focuses on increasing contraception, it will prevent more than 29% of HIV infection at birth. Therefore, the aim of this study was to assess utilization of dual contraceptive  method and associated factors among reproductive age women on antiretroviral therapy in selected public hospitals of Mekelle town, Northern Ethiopia.

Methods

Institution based cross-sectional survey was conducted in selected public hospitals of Mekelle among women under antiretroviral therapy from March 1–April 31, 2016. We used a systematic sampling technique to select 331 women. A pretested interviewer administered questionnaire was used for data collection. The data were entered in to Epi data version 3.1 and exported to SPSS version 20 for analysis. Bivariate and multivariable logistic regression analysis was computed. Odds ratio along with 95% CI was computed to ascertain the association. Statistical tests at p-value of < 0.05 were considered as cut off point to determine statistical significance.

Results

Only 51(15.7%) of participants have utilized dual contraception method. Being single[AOR 5.43, 95% CI (1.61, 18.32)] and cohabitated [AOR 6.06; 95% CI: (2.16, 16.95)] in marital status, having HIV negative partner [AOR 4.44; 95% CI: (1.23, 16.04)], exposure to post diagnosis counseling [AOR 3.03; 95% CI: 1.34, 6.80], disclosed HIV status [AOR 6.06; 95% CI: (1.78, 20.87)] and discussing safer sex with partner [AOR 6.96; 95% CI: (2.75, 16.62)] were positively associated with utilization of dual contraceptive method.

Conclusion

The overall magnitude of dual contraceptive use is still low in this study. This will be a great concern on the transmission of the virus from mother to babies and partners and risk of complications following unintended pregnancy. This will continue to present as major public health problems in the region unless future interventions focuses on the barriers through tailored counseling and husband involvement in all aspects of the HIV/AIDS care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Oni EE, Ross A. Linde Svd. Contraceptive practices amongst HIV-positive women on antiretroviral therapy attending an ART clinic in South Africa. Afr J Prim Health Care Faily Med. 2013;5(1):1–6. Oni EE, Ross A. Linde Svd. Contraceptive practices amongst HIV-positive women on antiretroviral therapy attending an ART clinic in South Africa. Afr J Prim Health Care Faily Med. 2013;5(1):1–6.
3.
go back to reference Agboghoroma CO. Contraception in the Context of HIV/AIDS: A review. Afr J Reprod Health. 2011;15(3):15–24.PubMed Agboghoroma CO. Contraception in the Context of HIV/AIDS: A review. Afr J Reprod Health. 2011;15(3):15–24.PubMed
4.
go back to reference Maraux B, Hamelin C, Bajos N, Dray-Spira R, Spire B, Lert F, Vespa study group. Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study. Contraception. 2011;92(2015):160-9. Maraux B, Hamelin C, Bajos N, Dray-Spira R, Spire B, Lert F, Vespa study group. Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study. Contraception. 2011;92(2015):160-9.
5.
go back to reference Workshop Group EC. Simultaneous prevention of unintended pregnancy and STIs: a challenging compromise. Hum Reprod Update. 2014;20(6):952–63.CrossRef Workshop Group EC. Simultaneous prevention of unintended pregnancy and STIs: a challenging compromise. Hum Reprod Update. 2014;20(6):952–63.CrossRef
6.
go back to reference Muyindike W, Fatch R, Steinfield R, Matthews TL, Musinguzi N, Emenyonu IN, et al. Contraceptive use and associated factors among women enrolling into HIV care in Southwestern Uganda. Infect Dis Obstet Gynecol, Hindawi Publishing Corporation .2012; 2012:1-9. doi:https://doi.org/10.1155/2012/340782. Muyindike W, Fatch R, Steinfield R, Matthews TL, Musinguzi N, Emenyonu IN, et al. Contraceptive use and associated factors among women enrolling into HIV care in Southwestern Uganda. Infect Dis Obstet Gynecol, Hindawi Publishing Corporation .2012; 2012:1-9. doi:https://​doi.​org/​10.​1155/​2012/​340782.
9.
go back to reference Marion WC, Hock-Long L, Kraft MJ, Henry-Moss D, Hatfield-Timajchy K, Merrill SM. Strategies for managing the dual risk of sexually transmitted infections and unintended pregnancy among Puerto Rican and African American young adults. Am J Public Health. 2012;102(3):449–56.CrossRef Marion WC, Hock-Long L, Kraft MJ, Henry-Moss D, Hatfield-Timajchy K, Merrill SM. Strategies for managing the dual risk of sexually transmitted infections and unintended pregnancy among Puerto Rican and African American young adults. Am J Public Health. 2012;102(3):449–56.CrossRef
11.
12.
go back to reference Lawani LO, Onyebuchi AK, Iyoke CA. Dual method use for protection of pregnancy and disease prevention among HIV-infected women in South East Nigeria. BMC Womens Health. 2014;14:39.CrossRefPubMedPubMedCentral Lawani LO, Onyebuchi AK, Iyoke CA. Dual method use for protection of pregnancy and disease prevention among HIV-infected women in South East Nigeria. BMC Womens Health. 2014;14:39.CrossRefPubMedPubMedCentral
14.
go back to reference Higgins AJ, Smith KN, Sanders AS, Schick V, Herb Nick D, Reece M, et al. Dual method use at last sexual encounter: A ntionally representative, episode-level analysis of US Men and Women. Contraception. 2014;90:399–406.CrossRefPubMedPubMedCentral Higgins AJ, Smith KN, Sanders AS, Schick V, Herb Nick D, Reece M, et al. Dual method use at last sexual encounter: A ntionally representative, episode-level analysis of US Men and Women. Contraception. 2014;90:399–406.CrossRefPubMedPubMedCentral
16.
go back to reference Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, Black V. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7(4):e36039.CrossRefPubMedPubMedCentral Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, Black V. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7(4):e36039.CrossRefPubMedPubMedCentral
17.
go back to reference WHO Guidelines Approved by the Guidelines Review Committee. Medical eligibility criteria for contraceptive use: A WHO Family Planning Cornerstone. 4th ed. Geneva: World Health Organization; 2010. WHO Guidelines Approved by the Guidelines Review Committee. Medical eligibility criteria for contraceptive use: A WHO Family Planning Cornerstone. 4th ed. Geneva: World Health Organization; 2010.
18.
go back to reference Wilson TE, Koenig LJ, Walter E, Fernandez I, Ethier K. Dual contraceptive method use for pregnancy and disease prevention among HIV infected and HIV uninfected women: the importance of an event-level focus for promoting safer sexual behaviors. Sex Transm Dis. 2003; 30(11):809-812. Pub Med Epub 2003/11/07.eng. Wilson TE, Koenig LJ, Walter E, Fernandez I, Ethier K. Dual contraceptive method use for pregnancy and disease prevention among HIV infected and HIV uninfected women: the importance of an event-level focus for promoting safer sexual behaviors. Sex Transm Dis. 2003; 30(11):809-812. Pub Med Epub 2003/11/07.eng.
20.
go back to reference Gyimah AA, Nakua EK, Owusu-Dabo E, Otupiri E. Contraceptive characteristics of women living with HIV in the Kumasi Metropolis, Ghana. Int J MCH AIDS. 2013;2(1):111–20.CrossRefPubMedPubMedCentral Gyimah AA, Nakua EK, Owusu-Dabo E, Otupiri E. Contraceptive characteristics of women living with HIV in the Kumasi Metropolis, Ghana. Int J MCH AIDS. 2013;2(1):111–20.CrossRefPubMedPubMedCentral
21.
go back to reference WHO HIV/AIDS Department. PMTCT strategic vision 2010–2015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals. Geneva: World Health Organization; 2010. WHO HIV/AIDS Department. PMTCT strategic vision 2010–2015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals. Geneva: World Health Organization; 2010.
22.
23.
go back to reference Patel NND, Newell ML, Coovadia HM, Rollins N, Coutsoudis A, Bland RM. Messages about dual contraception in areas of high HIV prevalence are not heeded. S Afr Med J. 2008;98(3):209–12.PubMed Patel NND, Newell ML, Coovadia HM, Rollins N, Coutsoudis A, Bland RM. Messages about dual contraception in areas of high HIV prevalence are not heeded. S Afr Med J. 2008;98(3):209–12.PubMed
26.
go back to reference Demissie DB, Girma T, Abdissa G. Dual contraceptive utilization and associated factors among people living with HIV attending ART clinic in Fitche Hospital, Ethiopia. J Health, Med Nurs. 2015;20:2422–8419. Demissie DB, Girma T, Abdissa G. Dual contraceptive utilization and associated factors among people living with HIV attending ART clinic in Fitche Hospital, Ethiopia. J Health, Med Nurs. 2015;20:2422–8419.
27.
go back to reference Udigwe GO, Mbachu II, Onyegbule OA, Oguaka V. Use of condoms among human immunodeficiency virus positive women attending antenatal clinic in Nnewi, South East Nigeria. Annal Med Health Sci. 2014;4(5):687-91. Udigwe GO, Mbachu II, Onyegbule OA, Oguaka V. Use of condoms among human immunodeficiency virus positive women attending antenatal clinic in Nnewi, South East Nigeria. Annal Med Health Sci. 2014;4(5):687-91.
28.
go back to reference Asfaw HM, Gashe FE. Contraceptive use and method preference among HIV positive women in Addis Ababa. Ethiopia BMC Public Health. 2014;14:566.CrossRefPubMed Asfaw HM, Gashe FE. Contraceptive use and method preference among HIV positive women in Addis Ababa. Ethiopia BMC Public Health. 2014;14:566.CrossRefPubMed
29.
go back to reference Tsigemariam T, Gail D. Which factors influence north Ethiopian adults‘use of dual protection from unintended pregnancy and HIV/AIDS? Ethiop J Health Dev. 2008:22(3):226–31. Tsigemariam T, Gail D. Which factors influence north Ethiopian adults‘use of dual protection from unintended pregnancy and HIV/AIDS? Ethiop J Health Dev. 2008:22(3):226–31.
30.
go back to reference Heard I, Potard V, Costagliola D, Kazatchkine MD. Contraceptive use in HIV-positive women. J Acquire Immune Deficiency Syndrom. 2004;36(2):714–20.CrossRef Heard I, Potard V, Costagliola D, Kazatchkine MD. Contraceptive use in HIV-positive women. J Acquire Immune Deficiency Syndrom. 2004;36(2):714–20.CrossRef
31.
go back to reference Sara ES, et al. Contraception use among Iranian women with HIV: a qualitative study. Global J Health Sci. 2016;8(1):1916–9736. Sara ES, et al. Contraception use among Iranian women with HIV: a qualitative study. Global J Health Sci. 2016;8(1):1916–9736.
33.
go back to reference Rhoda KW, et al. Fertility and contraceptive decision-making and support for HIV infected individuals: client and provider experiences and perceptions at two HIV clinics in Uganda. BMC Public Health. 2013;13:98.CrossRef Rhoda KW, et al. Fertility and contraceptive decision-making and support for HIV infected individuals: client and provider experiences and perceptions at two HIV clinics in Uganda. BMC Public Health. 2013;13:98.CrossRef
Metadata
Title
Utilization of dual contraception method among reproductive age women on antiretroviral therapy in selected public hospitals of Northern Ethiopia
Authors
Solomon Weldemariam Gebrehiwot
Gedion Asnake Azeze
Carmen C. Robles
Yohannes Mehretie Adinew
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Reproductive Health / Issue 1/2017
Electronic ISSN: 1742-4755
DOI
https://doi.org/10.1186/s12978-017-0390-6

Other articles of this Issue 1/2017

Reproductive Health 1/2017 Go to the issue